Spring may be nearly two weeks away, but winter seems to be making (at least!) one last stand.
“We think there’s going to be a storm developing across the South this weekend, bringing heavy rains and thunderstorms to portions of the southeastern U.S,” Jon Porter, VP and head of AccuWeather Enterprise Solutions, told Cheddar.
“It does look like that’s going to be a threat to the Middle Atlantic and Northeast as we head into Sunday and Monday.”
The East Coast is still recovering from the second nor'easter to hit the region in the past week.
Just Wednesday, a New Jersey school teacher was struck by lighting during the thundersnow, and some New Yorkers were barricaded by up to 26 inches of snow. The snow fell at a rate of two to three inches per hour.
By Thursday morning, Winter Storm Quinn had left more than 1 million people without power. Porter told Cheddar that it’s going to take some time before everything is restored.
While a storm this weekend is not a “sure bet,” Porter told Cheddar “it’s something to watch as we head into the next several days.”
For the full interview, [click here](https://cheddar.com/videos/recapping-the-damage-of-winter-storm-quinn).
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
